| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Molecular Biology and Genetics |
The Albert Einstein Cancer Center, Departments of Developmental and Molecular Biology [B. B., M. F., A. I., R. G. P.], Medicine [A. I., R. G. P.], and Neurology [A. I.], Albert Einstein College of Medicine, Bronx, New York 10461, and Laboratory of Experimental Carcinogenesis, National Cancer Institute, NIH, Bethesda, Maryland 20892-4255 [V. M. F., S. S. T.]
Transforming growth factor (TGF)-ß1 functions as a tumor suppressor in vivo. Using transgenic mice, we show that hepatic TGF-ß1 overexpression inhibits abundance of the cyclin-dependent kinase activating tyrosine phosphatase cdc25A protein. The reduction in cdc25A protein levels was associated with increased binding of histone deacetylase 1 to p130 in the hepatic extracts. In cultured cells, HDAC1/p130 overexpression inhibited activity of the cdc25A promoter through an E2F site. TGF-ß1 treatment enhanced p130 binding to the cdc25A promoter E2F site assessed in chromatin immunoprecipitation assays. Hepatic proliferation induced by partial hepatectomy was associated with a decrease in the amount of HDAC1 bound to p130, without a significant decrease in p130 abundance, suggesting that HDAC1 binding to p130 may be regulated by proliferative stimuli. The induction of cdc25A abundance induced by partial hepatectomy correlated with the induction of DNA synthesis. These studies suggest that TGF-ß1 may enhance HDAC1 binding to p130 in vivo, thereby inhibiting cdc25A gene expression. TGF-ß1 regulation of HDAC1/pocket protein associations may provide a link between chromatin remodeling proteins and cdk inhibition through induction of cdc25A in vivo.
This article has been cited by other articles:
![]() |
M. Fu, M. Rao, T. Bouras, C. Wang, K. Wu, X. Zhang, Z. Li, T.-P. Yao, and R. G. Pestell Cyclin D1 Inhibits Peroxisome Proliferator-activated Receptor {gamma}-mediated Adipogenesis through Histone Deacetylase Recruitment J. Biol. Chem., April 29, 2005; 280(17): 16934 - 16941. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. C. McKarns, R. H. Schwartz, and N. E. Kaminski Smad3 Is Essential for TGF-{beta}1 to Suppress IL-2 Production and TCR-Induced Proliferation, but Not IL-2-Induced Proliferation J. Immunol., April 1, 2004; 172(7): 4275 - 4284. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Haller, L. Holt, S. C. Kim, R. F. Schwabe, R. B. Sartor, and C. Jobin Transforming Growth Factor-{beta}1 Inhibits Non-pathogenic Gramnegative Bacteria-induced NF-{kappa}B Recruitment to the Interleukin-6 Gene Promoter in Intestinal Epithelial Cells through Modulation of Histone Acetylation J. Biol. Chem., June 20, 2003; 278(26): 23851 - 23860. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Strieder and W. Lutz E2F Proteins Regulate MYCN Expression in Neuroblastomas J. Biol. Chem., January 24, 2003; 278(5): 2983 - 2989. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Macias-Silva, W. Li, J. I. Leu, M. A. S. Crissey, and R. Taub Up-regulated Transcriptional Repressors SnoN and Ski Bind Smad Proteins to Antagonize Transforming Growth Factor-beta Signals during Liver Regeneration J. Biol. Chem., August 2, 2002; 277(32): 28483 - 28490. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Wu, C. Wang, M. D'Amico, R. J. Lee, C. Albanese, R. G. Pestell, and S. Mani Flavopiridol and Trastuzumab Synergistically Inhibit Proliferation of Breast Cancer Cells: Association with Selective Cooperative Inhibition of Cyclin D1-dependent Kinase and Akt Signaling Pathways Mol. Cancer Ther., July 1, 2002; 1(9): 695 - 706. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Fu, C. Wang, J. Wang, X. Zhang, T. Sakamaki, Y. G. Yeung, C. Chang, T. Hopp, S. A. W. Fuqua, E. Jaffray, et al. Androgen Receptor Acetylation Governs trans Activation and MEKK1-Induced Apoptosis without Affecting In Vitro Sumoylation and trans-Repression Function Mol. Cell. Biol., May 15, 2002; 22(10): 3373 - 3388. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. J. P. L. Kops, R. H. Medema, J. Glassford, M. A. G. Essers, P. F. Dijkers, P. J. Coffer, E. W.-F. Lam, and B. M. T. Burgering Control of Cell Cycle Exit and Entry by Protein Kinase B-Regulated Forkhead Transcription Factors Mol. Cell. Biol., April 1, 2002; 22(7): 2025 - 2036. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. X. Nguyen, T. F. Westbrook, and D. J. McCance Human Papillomavirus Type 16 E7 Maintains Elevated Levels of the cdc25A Tyrosine Phosphatase during Deregulation of Cell Cycle Arrest J. Virol., January 15, 2002; 76(2): 619 - 632. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. T. Reutens, M. Fu, C. Wang, C. Albanese, M. J. McPhaul, Z. Sun, S. P. Balk, O. A. Jänne, J. J. Palvimo, and R. G. Pestell Cyclin D1 Binds the Androgen Receptor and Regulates Hormone-Dependent Signaling in a p300/CBP-Associated Factor (P/CAF)-Dependent Manner Mol. Endocrinol., May 1, 2001; 15(5): 797 - 811. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |